期刊文献+

遗传性神经系统离子通道病基因治疗的研究进展

Progress in Gene Therapy of Hereditary Neurological Ion Channel Disease
原文传递
导出
摘要 目的遗传性神经系统离子通道病现有的治疗方法往往难以控制病情或者患者耐受度较低,因此探索新的治疗方法势在必行。基因治疗在多项研究中显示可能应用于神经系统疾病,并可能成为未来遗传性神经系统离子通道病的有效治疗手段。同时,光遗传学、化学遗传学方法、基因编辑技术的不断进步也为遗传性神经系统离子通道病的基因治疗提供了良好的发展基础。我们将就遗传性神经系统离子通道病基因治疗的方法机制、转导载体、启动子及给药途径作一综述。 Current therapies for hereditary neuropathy are often difficult to control or have low patient tolerance,so it is imperative to explore new therapies.Gene therapy has been shown that in many studies it may be applied to nervous system diseases and may become an effective treatment for hereditary nervous system ion channel diseases in the future.At the same time,the continuous progress of photogenetics,chemical genetics and gene editing technology also provides a good basis for the development of gene therapy for hereditary neuropathy.We will review the methods,mechanisms,transduction vectors,promoters and administration routes of gene therapy for hereditary neurological ion channel disease.
作者 王小艺 苏文娜 薛天阔 朱雨岚 Wang Xiaoyi;Su Wenna;Xue Tiankuo;Zhu Yulan(Department of Neurology,the Second Affiliated Hospital of Harbin Medical University,Harbin 150081,China)
出处 《中国综合临床》 2019年第4期381-384,共4页 Clinical Medicine of China
关键词 离子通道病 基因治疗 基因编辑 CRISPR/Cas9 Ion channel disease Gene therapy Gene editing CRISPR/Cas9
  • 相关文献

参考文献3

二级参考文献16

  • 1Suzuki T, Delgado-Escueta AV, Aguan K, et al.Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet,2004,36:842-849.
  • 2Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na^+ -channel β1 subunit gene SCN1B. Nat Genet,1998,19:366-370.
  • 3Weiss LA, Escayg A, Kearney JA, et al. Sodium channels SCN1A,SCN2A and SCN3A in familial autism. Mol Psychiatry,2003,8:186-194.
  • 4Dichgans M, Freilingar T, Eckstein G, et al. Mutation in the neuronal voltaga-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet,2005,366:371-377.
  • 5Chen Y, Lu J, Pan H, et al.Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol,2003,54:239-243.
  • 6Bowser DN, Wagner DA, Czajkowski C, et al. Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)]found in human epilepsy. Proc Natl Acad Sci USA ,2002,99:15170-15175.
  • 7Steinlein OK, Magnusson A, Stoodt J, et al.An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet, 1997,6:943-947.
  • 8Chang BS, Lowenstein DH. Epilepsy. N Engl J Med, 2003,349:1257-1266.
  • 9Mulley JC, Scheffer IE, Harkin LA, et al. Susceptibility genes for complex epilepsy. Hum Mol Genet, 2005,14:243-249.
  • 10Fukuma G, Oguni H, Shirasaka Y, et al.Mutations of neuronal voltage-gated Na^+ channel α1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI(SMEB). Epilepsia ,2004,45 : 140-148.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部